Literature DB >> 36271256

Mechanism and treatment of α-amanitin poisoning.

Jinfang Xue1, Xiran Lou1, Deyuan Ning1, Ruifei Shao1, Guobing Chen2.   

Abstract

Amanita poisoning has a high mortality rate. The α-amanitin toxin in Amanita is the main lethal toxin. There is no specific detoxification drug for α-amanitin, and the clinical treatment mainly focuses on symptomatic and supportive therapy. The pathogenesis of α-amanitin mainly includes: α-amanitin can inhibit the activity of RNA polymeraseII in the nucleus, including the inhibition of the largest subunit of RNA polymeraseII, RNApb1, bridge helix, and trigger loop. In addition, α-amanitin acts in vivo through the enterohepatic circulation and transport system. α-Amanitin can cause the cell death. The existing mechanisms of cell damage mainly focus on apoptosis, oxidative stress, and autophagy. In addition to the pathogenic mechanism, α-amanitin also has a role in cancer treatment, which is the focus of current research. The mechanism of action of α-amanitin on the body is still being explored.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Amanita poisoning; Mechanism; Treatment; α-Amanitin

Year:  2022        PMID: 36271256     DOI: 10.1007/s00204-022-03396-x

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   6.168


  83 in total

Review 1.  Programmed cell death (PCD). Apoptosis, autophagic PCD, or others?

Authors:  W Bursch; A Ellinger; C Gerner; U Fröhwein; R Schulte-Hermann
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  Structural basis of transcription: alpha-amanitin-RNA polymerase II cocrystal at 2.8 A resolution.

Authors:  David A Bushnell; Patrick Cramer; Roger D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria.

Authors:  Yoshimi Arima; Masayuki Nitta; Shinji Kuninaka; Dongwei Zhang; Toshiyoshi Fujiwara; Yoichi Taya; Mitsuyoshi Nakao; Hideyuki Saya
Journal:  J Biol Chem       Date:  2005-03-07       Impact factor: 5.157

Review 4.  Strategies and challenges for the next generation of antibody-drug conjugates.

Authors:  Alain Beck; Liliane Goetsch; Charles Dumontet; Nathalie Corvaïa
Journal:  Nat Rev Drug Discov       Date:  2017-03-17       Impact factor: 84.694

5.  Animal DNA-dependent RNA polymerases. 11. Mechanism of the inhibition of RNA polymerases B by amatoxins.

Authors:  M Cochet-Meilhac; P Chambon
Journal:  Biochim Biophys Acta       Date:  1974-06-27

6.  The cyclopeptide <alpha>-amatoxin induced hepatic injury via the mitochondrial apoptotic pathway associated with oxidative stress.

Authors:  Xiao Chen; Bing Shao; Chengmin Yu; Qunmei Yao; Peibin Ma; Haijiao Li; Wenjian Cai; Hao Fu; Bin Li; Chengye Sun
Journal:  Peptides       Date:  2020-05-07       Impact factor: 3.750

7.  Acute mushroom poisoning of Amanita pseudosychnopyramis: A case report from Fujian, China with exact species identification and descriptive study.

Authors:  Jing-Ze Chen; Wu-Sheng Fu; Fei Xu; Qin-Mei Fang; Kui-Cheng Zheng; Zhong Lin; Yi-Ming Lin; Sophia Zhang
Journal:  Toxicon       Date:  2022-04-06       Impact factor: 3.033

8.  Action of alpha-amanitin during pyrophosphorolysis and elongation by RNA polymerase II.

Authors:  D R Chafin; H Guo; D H Price
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

9.  Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP).

Authors:  Zhongqi Dong; Sean Ekins; James E Polli
Journal:  Mol Pharm       Date:  2013-02-12       Impact factor: 4.939

10.  NTCP deficiency in mice protects against obesity and hepatosteatosis.

Authors:  Joanne M Donkers; Sander Kooijman; Davor Slijepcevic; Roni F Kunst; Reinout Lp Roscam Abbing; Lizette Haazen; Dirk R de Waart; Johannes Hm Levels; Kristina Schoonjans; Patrick Cn Rensen; Ronald Pj Oude Elferink; Stan Fj van de Graaf
Journal:  JCI Insight       Date:  2019-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.